Withdrawal of immunosuppression in liver transplantation: lessons learned from PTLD.
Mazariegos
George V
GV
D002648:Child; D020031:Epstein-Barr Virus Infections / Q000209:etiology / Q000628:therapy; D006084:Graft Rejection; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage* / Q000009:adverse effects; D016031:Liver Transplantation / Q000009:adverse effects*; D008232:Lymphoproliferative Disorders / Q000209:etiology / Q000628:therapy* / Q000821:virology
D007166:Immunosuppressive Agents